The role of serotonin in tumour growth (Review)

Oncology Reports

Volumn 14, Issue 6, 2005, Pages 1593-1597

  Siddiqui, Emad J ^a   Thompson, Cecil S ^a   Mikhailidis, Dimitri P ^a   Mumtaz, Faiz H ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Growth factor; Proto oncogenes; Serotonin; Tumoural and non tumoural cells

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 (2 PHTHALIMIDO)BUTYL)PIPERAZINE; 1-(2-METHOXYPHENYL)-4-(4-(2-PHTHALIMIDO)BUTYL)PIPERAZINE; PIPERAZINE DERIVATIVE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST;

CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; NEOPLASMS; PIPERAZINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 33644689195     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.6.1593     Document Type: Review

References (72)

1. Abdul M, Anezinis PE, Logothetis CJ and Hoosein NM: Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonists. Anticancer Res 14: 1215-1220, 1994. (Pubitemid 24272593)
2. Abdul M, Logothetis CJ and Hoosein NM: Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines. J Urol 154: 247-250, 1995.
3. Dizeyi N, Bjartell A, Nilsson E, Hansson J, Gadaleanu V, Cross N and Abrahamsson PA: Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines. Prostate 59: 328-336, 2004. (Pubitemid 38509766)
4. Shields PJ and Eccleston D: Evidence for the synthesis and storage of 5-hydroxytryptamine in two separate pools in the brain. J Neurochem 20: 881-888, 1973.
5. Marmaras VJ and Mimikos N: Enzymic formation of serotonin in mammalian blood platelets and red cells. Experientia 27: 196-197, 1971.
6. Cortellazzo S, Viero P, Buczko W, Barbui T and de Gaetano G: Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disorders. Scand J Haematol 34: 146-151, 1985. (Pubitemid 15158494)
7. Yazaki T, Inage H, Iizumi T, Koyama A, Kanoh S, Koiso K, Narita M and Tojo S: Studies on platelet function in patients with prostatic cancer. Preliminary report. Urology 30: 60-63. 1987. (Pubitemid 17092293)
8. Abrahamsson PA, Wadstrom LB, Alumets J, Falkmer S and Grimelius L: Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands. Pathol Res Pract 181: 675-683, 1986. (Pubitemid 17230940)
9. Stahl SM: Neuroendocrine markers of serotonin responsivity in depression. Prog Neuropsychopharmacol Biol Psychiatry 16: 655-659, 1992.
10. Julius D, Livelli TJ, Jessell TM and Axel R: Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science 244: 1057-1062, 1989. (Pubitemid 19152293)
11. Alhaider AA and Wilcox GL: Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther 265: 378-385, 1993. (Pubitemid 23320985)
12. Anzini M, Vomero S, Garofalo A, Cappelli A and Cagnotto A: Synthesis and 5HT-receptors affinity of some 4-phenylquinoline derivatives. Farmaco 44: 555-563, 1989. (Pubitemid 19222886)
13. Boess FG, Sepulveda MI, Lummis SC and Martin IL: 5-HT3 receptors in NG108-15 neuroblastoma x glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide. Neuropharmacology 31: 561-564, 1992.
14. Dickenson JM and Hill SJ: Human 5-HT1B receptor stimulated inositol phospholipid hydrolysis in CHO cells: synergy with Gq-coupled receptors. Eur J Pharmacol 348: 279-285, 1998. (Pubitemid 28275593)
15. Goadsby PJ: Serotonin receptors and the acute attack of migraine. Clin Neurosci 5: 18-23, 1998.
16. Peroutka SJ: 5-Hydroxytryptamine receptor subtypes. Annu Rev Neurosci 11: 45-60, 1988.
17. Marazziti D, Marracci S, Palego L, Rotondo A, Mazzanti C, Nardi I, Ladinsky H, Giraldo E, Borsini F and Cassano GB: Localization and gene expression of serotonin 1A (5HT1A) receptors in human brain postmortem. Brain Res 658: 55-59, 1994. (Pubitemid 24291703)
18. Jagroop IA and Mikhailidis DP: Doxazosin, an alpha1-adrenoceptor antagonist, inhibits serotonin-induced shape change in human platelets. J Hum Hypertens 15: 203-207, 2001. (Pubitemid 32181487)
19. Khan MA, Thompson CS, Dashwood MR, Mumtaz FH, Mikhailidis DP and Morgan RJ: Doxazosin modifies serotonin-mediated rabbit urinary bladder contraction. Potential clinical relevance. Urol Res 28: 116-121, 2000. (Pubitemid 30397414)
20. Lefebvre H, Carrier D, Duparc C, Lihrmann I, Contesse V, Delarue C, Godin M, Fischmeister R, Vaudry H and Kuhn JM: Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies. J Clin Endocrinol Metab 87: 1211-1216, 2002. (Pubitemid 36121090)
21. Berendsen HH and Broekkamp CL: Drug-induced penile erections in rats: indications of serotonin1B receptor mediation. Eur J Pharmacol 135: 279-287, 1987. (Pubitemid 17057552)
22. Cohen ML and Wittenauer LA: Further evidence that the serotonin receptor in the rat stomach fundus is not 5HT1A or 5HT1B. Life Sci 38: 1-5, 1986. (Pubitemid 16147616)
23. Cohen ML and Fludzinski LA: Contractile serotonergic receptor in rat stomach fundus. J Pharmacol Exp Ther 243: 264-269, 1987. (Pubitemid 17162727)
24. Matsumoto I, Combs MR and Jones DJ: Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release. J Pharmacol Exp Ther 260: 614-626, 1992.
25. Wirtshafter D and Cook DF: Serotonin-1B agonists induce compartmentally organized striatal Fos expression in rats. Neuroreport 9: 1217-1221, 1998. (Pubitemid 28266652)
26. Feletou M, Dellazuana O and Duhault J: Serotoninergic receptor subtype in coronary artery smooth muscle from young and atherosclerotic rabbit. J Pharmacol Exp Ther 268: 124-132, 1994. (Pubitemid 24039078)
27. Wurch T, Palmier C, Colpaert FC and Pauwels PJ: Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors. Br J Pharmacol 120: 153-159, 1997. (Pubitemid 27042574)
28. Rajamannan NM, Caplice N, Anthikad F, Sebo TJ, Orszulak TA, Edwards WD, Tajik J and Schwartz RS: Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects. J Heart Valve Dis 10: 827-831, 2001. (Pubitemid 33133581)
29. Fenrick R, Pou C, Beliveau M and Fargin A: The human 5-hydroxytryptamine 1A receptor differentially modulates phospholipase C and adenylyl cyclase activities. Gen Pharmacol 27: 263-268, 1996. (Pubitemid 26130495)
30. Seuwen K and Pouyssegur J: Serotonin as a growth factor. Biochem Pharmacol 39: 985-990, 1990. (Pubitemid 20103670)
31. Nemecek GM, Coughlin SR, Handley DA and Moskowitz MA: Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci USA 83: 674-678, 1986. (Pubitemid 16035536)
32. Vicaut E, Laemmel E and Stucker O: Impact of serotonin on tumour growth. Ann Med 32: 187-194, 2000. (Pubitemid 30237564)
33. Ishizuka J, Beauchamp RD, Townsend CM Jr, Greeley GH Jr and Thompson JC: Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells. J Cell Physiol 150: 1-7, 1992.
34. Takuwa N, Ganz M, Takuwa Y, Sterzel RB and Rasmussen H: Studies of the mitogenic effect of serotonin in rat renal mesangial cells. Am J Physiol 257: F431-F439, 1989.
35. Cattaneo MG, Codignola A, Vicentini LM, Clementi F and Sher E: Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma. Cancer Res 53: 5566-5568, 1993. (Pubitemid 23342185)
36. Cattaneo MG, Fesce R and Vicentini LM: Mitogenic effect of serotonin in human small cell lung carcinoma cells via both 5-HT1A and 5-HT1D receptors. Eur J Pharmacol 291: 209-211, 1995.
37. Rudzit EA and Mal'tseva LF: [5-hydroxytryptamine and neoplasm growth]. Patol Fiziol Eksp Ter 14: 84-93, 1970.
38. Codignola A, Tarroni P, Clementi F, Pollo A, Lovallo M, Carbone E and Sher E: Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines. J Biol Chem 268: 26240-26247, 1993. (Pubitemid 23361693)
39. Dolezel S, Filkuka J, Tomasek V and Vlasin Z: Histochemical demonstration of 5-hydroxytryptamin in a malignant carcinoid of the small intestine. Neoplasma 16: 209-214, 1969.
40. Tutton PJ and Barkla DH: The influence of serotonin on the mitotic rate in the colonic crypt epithelium and in colonic adenocarcinoma in rats. Clin Exp Pharmacol Physiol 5: 91-94, 1978. (Pubitemid 9038475)
41. Tutton PJ and Steel GG: Influence of biogenic amines on the growth of xenografted human colorectal carcinomas. Br J Cancer 40: 743-749, 1979. (Pubitemid 10204793)
42. Tutton PJ and Barkla DH: Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas. Br J Cancer 46: 260-265, 1982. (Pubitemid 12053078)
43. Zimmerman D, Abboud HE, George LE, Edis AJ and Dousa TP: Serotonin stimulates adenosine 3′,5′-monophosphate accumulation in parathyroid adenoma. J Clin Endocrinol Metab 51: 1274-1278, 1980. (Pubitemid 11199612)
44. Skolnik G, Bagge U, Blomqvist G, Dahlstrom A and Ahlman H: Involvement of platelet-released 5-HT in tumor cell lodgement. J Surg Res 38: 559-567, 1985. (Pubitemid 16211170)
45. Siddiqui EJ, Shabbir M, Thompson CS, Mumtaz FH and Mikhailidis DP: Growth inhibitory effect of doxazosin on prostate and bladder cancer cells. Is the serotonin receptor pathway involved? Anticancer Res (In press): 2005.
46. Di Sant'Agnese PA and Mesy Jensen KL: Neuroendocrine differentiation in prostatic carcinoma. Hum Pathol 18: 849-856, 1987. (Pubitemid 18049858)
47. Di Sant'Agnese PA: Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications. Cancer 70: 254-268, 1992.
48. Di Sant'Agnese PA: Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol 23: 287-296, 1992.
49. Di Sant'Agnese PA and Cockett AT: The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research. J Urol 152: 1927-1931, 1994. (Pubitemid 24322661)
50. Di Sant'Agnese PA and Cockett AT: Neuroendocrine differentiation in prostatic malignancy. Cancer 78: 357-361, 1996. (Pubitemid 26234584)
51. Di Sant'Agnese PA: Neuroendocrine differentiation in prostatic carcinoma: an update. Prostate Suppl 8: 74-79, 1998.
52. Di Sant'Agnese PA: Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects. Urology 51: 121-124, 1998.
53. Bonkhoff H and Fixemer T: [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype]. Urologe A 43: 836-842, 2004.
54. Abrahamsson PA: Neuroendocrine differentiation and hormone-refractory prostate cancer. Prostate Suppl 6: 3-8, 1996.
55. Hansson J and Abrahamsson PA: Neuroendocrine pathogenesis in adenocarcinoma of the prostate. Ann Oncol 12 (Suppl 2): S145-S152, 2001. (Pubitemid 33069705)
56. Aprikian AG, Cordon-Cardo C, Fair WR and Reuter VE: Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 71: 3952-3965, 1993. (Pubitemid 23172976)
57. Aprikian AG, Cordon-Cardo C, Fair WR, Zhang ZF, Bazinet M, Hamdy SM and Reuter VE: Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. J Urol 151: 914-919, 1994. (Pubitemid 24083459)
58. Lertprasertsuke N and Tsutsumi Y: Neuroendocrine carcinoma of the urinary bladder: case report and review of the literature. Jpn J Clin Oncol 21: 203-210, 1991.
59. Mills SE, Wolfe JT III, Weiss MA, Swanson PE, Wick MR, Fowler JE Jr and Young RH: Small cell undifferentiated carcinoma of the urinary bladder. A light-microscopic, immunocytochemical, and ultrastructural study of 12 cases. Am J Surg Pathol 11: 606-617, 1987. (Pubitemid 17128979)
60. Acs G, Gupta PK and Baloch ZW: Cytomorphology of high-grade neuroendocrine carcinoma of the urinary tract. Diagn Cytopathol 23: 92-96, 2000.
61. Amichetti M, Boi S, Fellin G, Maluta S, Dalla PP and Luciani L: Small cell carcinoma of the urinary bladder. Report of two cases and review of the literature. Tumori 78: 409-413, 1992. (Pubitemid 23147239)
62. Blomjous CE, Thunnissen FB, Vos W, De Voogt HJ and Meijer CJ: Small cell neuroendocrine carcinoma of the urinary bladder. An immunohistochemical and ultrastructural evaluation of 3 cases with a review of the literature. Virchows Arch A Pathol Anat Histopathol 413: 505-512, 1988.
63. Blomjous CE, Vos W, De Voogt HJ, Van der Valk P and Meijer CJ: Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer 64: 1347-1357, 1989. (Pubitemid 19217117)
64. Chin NW, Marinescu AM and Fani K: Composite adenocarcinoma and carcinoid tumor of urinary bladder. Urology 40: 249-252, 1992.
65. Dundr P, Pesl M, Povysil C, Vitkova I and Dvoracek J: Large cell neuroendocrine carcinoma of the urinary bladder with lympho-epithelioma- like features. Pathol Res Pract 199: 559-563, 2003. (Pubitemid 37193079)
66. Grignon DJ, Ro JY, Ayala AG, Shum DT, Ordonez NG, Logothetis CJ, Johnson DE and Mackay B: Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Cancer 69: 527-536, 1992.
67. Helpap B and Kloppel G: Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge. Virchows Arch 440: 241-248, 2002. (Pubitemid 34230727)
68. Martignoni G and Eble JN: Carcinoid tumors of the urinary bladder. Immunohistochemical study of 2 cases and review of the literature. Arch Pathol Lab Med 127: e22-e24, 2003.
69. Mazzucchelli L, Kraft R, Gerber H, Egger C, Studer UE and Zimmermann A: Carcinosarcoma of the urinary bladder: a distinct variant characterized by small cell undifferentiated carcinoma with neuroendocrine features. Virchows Arch A Pathol Anat Histopathol 421: 477-483, 1992. (Pubitemid 23008252)
70. Swanson PE, Brooks R, Pearse H and Stenzel P: Small cell carcinoma of urinary bladder. Urology 32: 558-563, 1988. (Pubitemid 19009330)
71. Van Hoeven KH and Artymyshyn RL: Cytology of small cell carcinoma of the urinary bladder. Diagn Cytopathol 14: 292-297, 1996. (Pubitemid 26177675)
72. Vincendeau S, Lajarte-Thirouard AS, Bensalah K, Guille F, Lobel B and Patard JJ: [Neuroendocrine differentiation of bladder tumors]. Prog Urol 13: 375-384, 2003.